White Paper: Accelerate your process development with high-throughput, one-time, fully automated bioreactors

Biopharmaceutical R&D teams around the world face the same dilemma in biopharmaceutical and vaccine development: they must increase productivity to meet stringent budgets and deadlines while maintaining or improving data accuracy.

To meet market demand, biopharmaceutical companies are increasingly using bioreactor technology that optimizes microbial fermentation and cell culture processes through high-throughput process development.

The most common obstacles that developers have to overcome from the analysis of process operation failures and production deceleration problems have found that automation has evolved from a “dispensable” technology to the necessary technology to maintain competitive advantages in biopharmaceutical and vaccine process development. The ambr®250 is an award-winning, one-time, high-throughput, fully automated bioreactor system. There are 12 or 24 reactor configurations available. The system is considered a “major breakthrough in biotechnology” and has recently won two major Biotechnology International (BPI) awards: Best Upstream Technology Application Award and Best Collaboration Award (cooperation between Tap Biosystems and Merck) . The ambr®250 is designed to change the operating model of your R&D lab, not only to increase productivity, rapid integration of people and laboratories, superior scalability, but also a return on investment in just one year.
As biopharmaceutical and vaccine development faces more intense competition and reduced budgets, you must adopt technologies that accelerate process development and optimization. Dr. Simon Dewar, head of Fujifilm Dioxin Biotechnology's upstream process development and operations department, said: “ambr®250 is the cutting-edge technology for microbial fermentation. I have been working on fermentation for 25 years, which is the only one I have ever seen. The best process to scale the fermentation system, its design is so perfect, it changes everything

abstract
1 Introduction
2. Costly failures and production slowdowns
3. Enter the ambr®250 era
4. Increase productivity
5. Rapid integration of people and laboratories
6. Excellent magnification
7. Key points: What is a return on investment (ROI)?
8. Conclusion

Download Chinese full text download English full text

Monobenzone

Monobenzone can decompose melanin in the skin, and prevent the formation of melanin in the skin, used for the treatment of hyperpigmentation, such as various spots, age spots, melanoma. In addition as intermediates in organic synthesis.

Our company offers variety of products which can meet your multifarious demands.including API Powder.Pharmaceutical Intermediates.Vitamins Powder.Plant Extracts.Food Additive.Peptide Powder and so on We adhere to the management principles of "quality first, customer first and credit-based" since the establishment of the company and always do our best to satisfy potential needs of our customers. Our company is sincerely willing to cooperate with enterprises from all over the world in order to realize a win-win situation since the trend of economic globalization has developed with anirresistible force.

Function: